Drug Enforcement Administration
Skip Navigation

Press Room
News Releases
E-mail updates red envelope
Speeches & Testimony
Multi-Media Library

About Us
Mission
Leadership
History
Organizational Chart
Programs & Operations
Wall of Honor
DEA Museum
Office Locations

Careers at DEA

Drug Information

Law Enforcement
Most Wanted
Major Operations
Threat Assessment
Training Programs
Stats & Facts
Additional Resources

Drug Prevention
For Young Adults
Additional Resources

Diversion Control & Prescription Drugs
Registration
Cases Against Doctors

Drug Policy
Controlled Substances Act
Federal Trafficking Penalties
Drug Scheduling

Legislative Resources

Publications

Acquisitions & Contracts


LSD

Description/Overview
Control Status
Street Names
Short-Term Effects
Long-Term Effects
Trafficking Trends
Use/User Population
Arrests/Sentencing
Treatment Resources
Photos

DESCRIPTION/OVERVIEW

Chemist Albert Hofmann, working at the Sandoz Corporation pharmaceutical laboratory in Switzerland, first synthesized LSD in 1938. He was conducting research on possible medical applications of various lysergic acid compounds derived from ergot, a fungus that develops on rye grass. Searching for compounds with therapeutic value, Hofmann created more than two dozen ergot-derived synthetic molecules.(1)

LSD is sold on the street in tablets, capsules, and occasionally in liquid form. It is an odorless and colorless substance with a slightly bitter taste that is usually ingested orally. It is often added to absorbent paper, such as blotter paper, and divided into small decorated squares, with each square representing one dose.(2)

CONTROL STATUS

LSD is a Schedule I substance under the Controlled Substances Act. Schedule I drugs, which include heroin and MDMA, have a high potential for abuse and serve no legitimate medical purpose.(3) Its two precursors lysergic acid and lysergic acid amide are both in Schedule III of the CSA. The LSD precursors ergotamine and ergonovine are List I chemicals.(4)

back to top

STREET TERMS

Acid, blotter acid, window pane, dots, mellow yellow

SHORT-TERM EFFECTS

The short-term effects of LSD are unpredictable. They depend on the amount of the drug taken; the user's personality, mood, and expectations; and the surroundings in which the drug is used. Usually, the user feels the first effects of the drug within 30 to 90 minutes of ingestion. These experiences last for extended periods of time and typically begin to clear after about 12 hours. The physical effects include dilated pupils, higher body temperature, increased heart rate and blood pressure, sweating, loss of appetite, sleeplessness, dry mouth, and tremors. Sensations may seem to "cross over" for the user, giving the feeling of hearing colors and seeing sounds. If taken in a large enough dose, the drug produces delusions and visual hallucinations.(5)

back to top

LONG-TERM EFFECTS

LSD users often have flashbacks, during which certain aspects of their LSD experience recur even though they have stopped taking the drug. In addition, LSD users may develop long-lasting psychoses, such as schizophrenia or severe depression. LSD is not considered an addictive drug - that is, it does not produce compulsive drug-seeking behavior as cocaine, heroin, and methamphetamine do. However, LSD users may develop tolerance to the drug, meaning that they must consume progressively larger doses of the drug in order to continue to experience the hallucinogenic effects that they seek.(6)

back to top

TRAFFICKING TRENDS

LSD trafficking and abuse have decreased sharply since 2000, and a resurgence does not appear likely in the near term. National-level data regarding LSD availability (such as LSD seizures and LSD-related arrests) show a sharp decrease since 2000. LSD seizures, for example, decreased 100 percent from 2000 through 2005, and LSD-related arrests decreased 84.9 percent from 2000 through 2004 (see 2006 National Drug Threat Assessment Appendix B, Table 4 and Table 5). Demand for LSD also has decreased sharply since 2000, as reflected in national-level prevalence studies. In fact, Monitoring the Future (MTF) and National Survey on Drug Use and Health (NSDUH) data show that rates of past year use for LSD have decreased significantly for nearly every sampled age group (see 2006 National Drug Threat Assessment Appendix B, Table 1 and Table 2). Production of the drug also appears to be limited--with no reported laboratory seizures in 2004--and controlled by a relatively small number of experienced chemists. Moreover, LSD distribution appears to be very limited in most areas of the country. As such, resurgence in widespread LSD distribution is unlikely in the near term.(7)

back to top

USE/USER POPULATION

LSD is abused by teenagers and young adults in connection with raves, nightclubs and concert settings.(8)

Approximately 1.9% of eighth graders, 2.5% of tenth graders, and 3.5% of twelfth graders surveyed as part of the 2005 Monitoring the Future study reported lifetime use of LSD. Approximately 44% of eighth graders, 60.8% of tenth graders, and 69.9% of twelfth graders surveyed in 2005 reported that taking LSD regularly was a "great risk." Additional survey results indicate that 5.6% of college students and 13.4% of young adults reported lifetime use of LSD.(9)

back to top

ARRESTS/SENTENCING

On March 31, 2003, William Leonard Pickard and Clyde Apperson were found guilty of one count of conspiracy to manufacture and distribute more than 10 grams of LSD from August 1999 to November 2000 and one count of possession with the intent to distribute more than 10 grams of LSD on November 6, 2000. The case involving these two individuals included the largest LSD lab seizure ever made by the DEA. Agents seized 41.3 kilograms of LSD and 23.6 kilograms of iso-LSD, a by-product from the manufacture of LSD. In the history of the DEA, there have only been 4 seizures of complete LSD labs. Three of these seizures involved Pickard and Apperson.(10) Click here for more information on this story.

TREATMENT RESOURCES

Treatment Publications and Research | Treatment and Patient Education | Treatment Facility Locator

PHOTOS

Click here to see high resolution photos of LSD>>

back to top

SOURCES

1. National Institute on Drug Abuse, Research Report: Hallucinogens and Dissociative Drugs, March 2001
2. National Institute on Drug Abuse, InfoFacts: LSD, February 2005
3. National Drug Intelligence Center (NDIC), LSD Fast Facts, May 2003
4. DEA Office of Diversion Control, d-Lysergic Acid Diethylamide
5. National Institute on Drug Abuse, Research Report: Hallucinogens and Dissociative Drugs, March 2001
6. NDIC, LSD Fast Facts, May 2003
7. NDIC, National Drug Threat Assessment 2006
8. DEA Office of Diversion Control, d-Lysergic Acid Diethylamide
9. National Institute on Drug Abuse and University of Michigan, Monitoring the Future 2005 Data From In-School Surveys of 8th-, 10th-, and 12th-Grade Students, December 2005
10. Drug Enforcement Administration, Press Release "Pickard and Apperson Convicted of LSD Charges: Largest LSD Lab Seizure in DEA History," March 31, 2003

Last updated: August 2006

Home USDOJ.GOV Privacy Policy Contact Us Site Map